Sponsor:
Dr. Daniel H. Chang, MD
Code:
NCT07213167
Conditions
Dysphotopsia
Posterior Capsule Opacification
Visual Acuity
Visual Function
Contrast Sensitivity
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
None-placebo
Brief summary:
Conditions
Dysphotopsia
Posterior Capsule Opacification
Visual Acuity
Visual Function
Contrast Sensitivity
Study ID
NCT07213167
Start date
Sep 24, 2025
Status verified date
Sep, 2026
Completion date
Dec, 2026
Anticipated
Primary completion date
Dec, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Arms
Tecnis Monofocals
Tecnis Symfony Optiblue
Tecnis Odyssey
Interventions
None-placebo
Primary outcome measure
Central contacts
Locations
Empire Eye and Laser Center
Recruiting
Bakersfield, California, United States, 93309
Contacts
Research Department
661-325-3937Principal Investigator:
Daniel H Chang, MD
Sponsor
Dr. Daniel H. Chang, MD
Last update posted
Sep 25, 2026
Last verified
Sep, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-24. This information was provided to ClinicalTrials.gov by Dr. Daniel H. Chang, MD on 2026-09-25. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.